Philip J. Rosenfeld

Philip J. Rosenfeld is an American ophthalmologist known for his pioneering work in the field of retinal diseases, particularly age-related macular degeneration. He has made significant contributions to developing innovative treatments, including the use of anti-vascular endothelial growth factor (anti-VEGF) therapies. These treatments help prevent vision loss by targeting abnormal blood vessel growth in the eye. Rosenfeld’s research has greatly influenced modern eye care, improving outcomes for patients with serious retinal conditions. His work exemplifies the integration of clinical practice and cutting-edge research in advancing medical science.